hyaluronoglucosaminidase has been researched along with Cross Infection in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (44.44) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, ZX; Du, Y; Guo, L; He, C; Kang, M; Liu, JY; Ou, QS; Wang, LL; Xie, Y; Yang, Q | 1 |
| Billström, H; Edlund, C; Lund, B; Top, J | 1 |
| Carias, L; Goossens, H; Huang, W; Klare, I; Konstabel, C; Murray, BE; Nallapareddy, SR; Rice, LB; Rudin, S; Vael, C | 1 |
| SZEREMI, K | 1 |
| Borgmann, S; Eigner, U; Fahr, AM; Jonas, D; Kettlitz, C; Klare, I; Konstabel, C; Mueller-Bertling, S; Schulte, B; Serr, A; Strommenger, B; Werner, G; Witte, W | 1 |
| Camargo, IL; Darini, AL; Gilmore, MS | 1 |
| Bülow, P | 2 |
| Kleber, I; Traub, WH | 1 |
1 review(s) available for hyaluronoglucosaminidase and Cross Infection
| Article | Year |
|---|---|
Spread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals.
Topics: Acetamides; Ampicillin Resistance; Anti-Infective Agents; Bacterial Proteins; Cross Infection; DNA Restriction Enzymes; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Germany; Gram-Positive Bacterial Infections; Humans; Hyaluronoglucosaminidase; Linezolid; Membrane Proteins; Oxazolidinones; Phenotype; Phylogeny; Polymerase Chain Reaction; Vancomycin Resistance | 2005 |
8 other study(ies) available for hyaluronoglucosaminidase and Cross Infection
| Article | Year |
|---|---|
Molecular characteristics of vancomycin-resistant Enterococcus faecium from a tertiary care hospital in Chengdu, China: molecular characteristics of VRE in China.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; Bacterial Proteins; China; Cross Infection; Enterococcus faecium; Genotype; Gram-Positive Bacterial Infections; Humans; Hyaluronoglucosaminidase; Membrane Proteins; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phenotype; Polymerase Chain Reaction; Tertiary Care Centers; Vancomycin Resistance; Virulence Factors | 2014 |
Frequent occurrence of multidrug-resistant CC17 Enterococcus faecium among clinical isolates in Sweden.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Hyaluronoglucosaminidase; Membrane Proteins; Microbial Sensitivity Tests; Multilocus Sequence Typing; Sweden | 2010 |
A potential virulence gene, hylEfm, predominates in Enterococcus faecium of clinical origin.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cross Infection; Enterococcus faecium; Genes, Bacterial; Humans; Hyaluronoglucosaminidase; Membrane Proteins; Vancomycin; Vancomycin Resistance; Virulence | 2003 |
[RELATIONS OF THE BIOCHEMICAL PROPERTIES OF STAPHYLOCOCCAL HOSPITAL INFECTION TO THEIR PHAGE TYPES].
Topics: Cross Infection; Drug Resistance; Drug Resistance, Microbial; Hemolysis; Humans; Hungary; Hyaluronoglucosaminidase; Hydrolases; Mannitol; Phosphoric Monoester Hydrolases; Proteins; Staphylococcal Infections; Staphylococcus; Staphylococcus Phages | 1963 |
Multilocus sequence typing and analysis of putative virulence factors in vancomycin-resistant and vancomycin-sensitive Enterococcus faecium isolates from Brazil.
Topics: Adhesins, Bacterial; Animals; Anti-Bacterial Agents; Bacterial Proteins; Brazil; Carrier State; Cross Infection; Enterococcus faecium; Feces; Gram-Positive Bacterial Infections; Hospitals; Humans; Hyaluronoglucosaminidase; Membrane Proteins; Microbial Sensitivity Tests; Species Specificity; Swine; Vancomycin; Vancomycin Resistance; Virulence Factors | 2006 |
A new epidemic phage type of Staphylococcus aureus. 4. Pathogenicity of type 83A-6557 and "type 6557".
Topics: Adolescent; Adult; Age Factors; Aged; Anti-Bacterial Agents; Bacteriophage Typing; Child; Child, Preschool; Cross Infection; Denmark; Drug Resistance, Microbial; Humans; Hyaluronoglucosaminidase; Infant; Middle Aged; Sepsis; Staphylococcal Infections; Staphylococcus; Staphylococcus Phages; Surface-Active Agents | 1968 |
Detection of fibrinolytic and elastase activity among clinical isolates of Serratia marcescens.
Topics: ABO Blood-Group System; Animals; Cross Infection; Deoxyribonucleases; DNA; Erythrocytes; Fibrinolysis; Gelatin; Hemolysis; Humans; Hyaluronoglucosaminidase; Hydrolysis; Lipase; Microbial Collagenase; Pancreatic Elastase; Phospholipases; Pigments, Biological; Rabbits; Serratia marcescens; Sheep; Urease | 1974 |
Prevalence of extrachromosomal drug resistance. Staphylococci in Danish hospitals during the last decade: factors influencing some properties of predominant epidemic strains.
Topics: Anti-Bacterial Agents; Bacteria; Bacteriophage Typing; Biological Evolution; Cross Infection; Denmark; Drug Resistance, Microbial; Hospitals; Humans; Hyaluronoglucosaminidase; Lipase; Lysogeny; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus; Transduction, Genetic | 1971 |